Hematology & Oncology

The Center for Cancer and Blood Disorders at Lurie Children’s treats more children with cancer and blood disorders than any other hospital in Illinois. Although cancer is rare in children, we treat 220 new patients each year for a wide range of childhood cancers. The center is ranked 12th in the nation by U.S.News & World Report for pediatric oncology.

We treat patients ranging in age from newborns to young adults. Families from throughout the Midwest and across the country come to Lurie Children’s to take advantage of resources that are not widely available. These services include:

Division Head Stewart Goldman, MD, is the Medical Director and Gus Foundation Chair of Neuro-oncology at Lurie Children’s. Dr. Goldman is a board-certified pediatric hematologist/oncologist with more than 15 years of experience in the field. An active physician researcher, he directs clinical trials research at Lurie Children’s Research Center. Dr. Goldman also is a Professor of Pediatrics at Northwestern University Feinberg School of Medicine.

Approach

We are committed to caring for each patient’s physical, emotional and social needs in a kid-friendly environment. We believe in family-centered care, which means we involve the whole family in a patient’s treatment plan. From bring family members into care plan meetings, to providing support and distraction to a patient’s siblings, we do our best to help fit our care within your lifestyle.

A multidisciplinary team of experienced healthcare providers will care for your child. This team approach makes it easier for you to see every specialist your child needs under one roof and often in the same visit. To meet all of your child’s needs, physicians in our center have access to specialists from 70 medical and surgical specialties at Lurie Children’s. Our physicians also work closely with pediatric radiation oncologists and other specialists at the nearby Robert H. Lurie Comprehensive Cancer Center of Northwestern University.

Research

Our center has a thriving research program, encompassing many groundbreaking studies in patients (clinical trials) as well as basic science investigations and translational research using a “bench to bedside” approach. Through research projects that we conduct at our own hospital and with other centers, we hope to:

Provide access to innovative treatments that are available only at a limited number of research centers

Improve the detection of pediatric brain tumors and blood disorders, and their complications

Discover safer, more effective treatments to prolong the patient’s life and enhance quality of life

Our physicians also spend their time training the next generation of specialists in pediatric cancer and blood disorders. Through our partnership with the Feinberg School, we offer a three-year pediatric hematology/oncology fellowship program and a one-year pediatric neuro-oncology fellowship.

Conditions

Make an Appointment

If you’d like to request an appointment with one of our specialists, call 1.800.543.7362 (1.800.KIDS DOC®). You can also request an appointment online.

Philanthropy

Funding from generous donors has helped to transform our cancer care. Your support is vital in helping us continue to make a difference in the lives of patients and families. Lurie Children’s relies on philanthropic funding to enhance its programs, services and research for children. To learn more, please e-mail Ann & Robert H. Lurie Children’s Hospital of Chicago Foundation at foundation@luriechildrens.org, call 312.227.7500 or make a gift today.​

​Transitioning to Home Care

Almost Home Kids (AHK), now part of the Lurie Children’s family, cares for children with complicated health needs by providing family training, respite care and short-term transitional care in a home-like setting. AHK is staffed with medical professionals and volunteers to make sure every child and their families are prepared for the return home. The Center for Cancer and Blood Disorders works closely with Almost Home Kids to make the care transition process as easy as possible.